SPY396.92+7.29 1.87%
DIA318.84+6.42 2.05%
IXIC11,535.28+180.66 1.59%

BRIEF-First Patient Enrolled In U.S. Star-D Trial Evaluating The Drugsorb-Atr Antithrombotic Removal System

reuters.com · 04/29/2022 07:19
BRIEF-First Patient Enrolled In U.S. Star-D Trial Evaluating The Drugsorb-Atr Antithrombotic Removal System

- Cytosorbents Corp CTSO:

  • FIRST PATIENT ENROLLED IN U.S. STAR-D PIVOTAL TRIAL EVALUATING THE DRUGSORB™-ATR ANTITHROMBOTIC REMOVAL SYSTEM TO REMOVE APIXABAN AND RIVAROXABAN DURING CARDIOTHORACIC SURGERY

Source text for Eikon: ID:nPn8rxjV1a

Further company coverage: CTSO


((reuters.briefs@thomsonreuters.com;))